Dr Robert Califf
President Joe Biden is set to appoint former Food and Drug Administration commissioner Dr. Robert Califf as head of the agency, the Washington Post reported Thursday.
Appointed by Obama, Califf led the FDA from February 2016 to February 2017 after a year as the agency’s deputy commissioner for medical products and tobacco, according to the FDA website. His appointment would mark the end of a nine-month search for a permanent successor to the acting commissioner, Dr. Janet Woodcock, who took over the acting agency in January.
Biden is due to appoint Woodcock or choose another full-time commissioner by mid-November, the Post reported. A White House official told the publication Biden has yet to make his selection, while Califf declined to comment.
Prior to joining the FDA, Califf was Duke University’s vice chancellor for clinical and translational research, according to the agency’s website. A cardiologist and a graduate of the university’s medical school, he headed Duke’s Translational Medicine Institute and founded the Duke Clinical Research Institute, the FDA said.
Read more about Califf’s potential appointment from the Washington Post.